Endothelin receptor antagonist gives renoprotection in selected patients with T2DM and CKD
Educational information
This video was recorded at the ISN World Congress of Nephrology in Melbourne, Australia, on April 15, 2019.
Faculty
Prof. Dick de Zeeuw, MD is director of the Groningen University Institute for Drug Exploration (GUIDE). He works at the Department of Clinical Pharmacology at the UMCG in Groningen, The Netherlands.
Disclosures
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: